5d
Verywell Health on MSNHow to Test for Atopic DermatitisA patch test for atopic dermatitis helps identify triggers and confirms diagnosis. Learn about self-testing and specialists ...
6h
Verywell Mind on MSNLiving With Atopic DermatitisThe visible symptoms only scratch the surface of this chronic skin condition Living with a chronic condition like atopic ...
4d
Verywell Health on MSNAsk an Expert: Can You Self-Diagnose Atopic Dermatitis?Deeptej Singh, MD, a board-certified dermatologist, discusses how to get a diagnosis of atopic dermatitis (eczema).
4d
News-Medical.Net on MSNBach2 protein identified as key regulator in atopic dermatitisAtopic dermatitis is an allergy affecting approximately 10% of the Japanese population, with symptoms closely related to ...
Atopic Dermatitis AD and Contact Dermatitis CD are skin conditions that lead to skin inflammation however their causes and ...
8h
Verywell Mind on MSNHow I Reframed the Way I Saw My Atopic DermatitisWhen my mind is struggling but I’m pretending I’m fine, my skin tells the truth My eczema doesn’t just show up on my skin—it ...
Underlying social and economic barriers in the U.S. may play a significant role in the higher rates of atopic dermatitis.
Miyake and Masakatsu Yamashita has discovered that Bach2, a protein essential for regulating T cells function, plays a ...
Dupilumab treatment of atopic dermatitis resulted in long-term skin improvements linked to changes in skin’s the molecular composition.
A cohort study finds children with early-onset atopic dermatitis to be at increased risk for uveitis, highlighting a need for ophthalmologic monitoring in youth.
Lilly’s recently-launched direct-to-consumer campaign also embraces a digital-first approach to reach eczema patients.
Atopic dermatitis highlights from AAD 2025 include phase 3 trial results on rocatinlimab and delgocitinib, findings on tapinarof 1% cream, and early dosing data on a new JAK1/TYK2 inhibitor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results